PD-L1 overexpression is correlated with poor prognosis in ALL (113) and has been found to be one of the most expressed inhibitory markers in pediatric ALL blast, whose expression is increased in relapsed patients with ALL (108, 115). This evidence concerns the gene CD274 and acute lymphoblastic leukemia.